Algie Aqueous (Sodium Alginate)

Adult dose

1. For hemostasis and improvement of subjective symptoms in gastric and duodenal ulcers and erosive gastritis, as well as improvement of subjective symptoms in gastroesophageal reflux disease: Sodium alginate is typically administered orally at a dose of 1–3g (20–60mL of this medication) 3–4 times a day on an empty stomach. If oral administration is not possible, it can be administered through a nasogastric tube using a sonde. 2. For hemostasis in gastric biopsy bleeding: This medication is typically administered endoscopically at a dose of 0.5–1.5g (10–30mL of this medication) and orally administered 1.5g (30mL of this medication).

This medication may occasionally cause gastrointestinal symptoms such as diarrhea or constipation during use. It is important to discontinue use immediately and consult a doctor or dentist if these symptoms occur. When consulting, be sure to bring the medication's instructions or accompanying documents to provide accurate information. Additionally, if there is insufficient gastric acid, this medication may not properly change into a gel form, thereby reducing its efficacy. Therefore, those with gastric acid deficiency should consider this when taking the medication and consult a professional if necessary.

Mild side effects

Symptoms such as diarrhea and constipation may occasionally occur.

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius at room temperature. This will help preserve the effectiveness of the medication for a longer period.

Appearance

A viscous liquid of green color contained in an aluminum foil pouch

Package unit

20mL/pack × 40, 25mL/pack × 40